These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 1676084)

  • 1. Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan.
    Friberg L; Olesen J; Iversen HK; Sperling B
    Lancet; 1991 Jul; 338(8758):13-7. PubMed ID: 1676084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ergotamine, flunarizine and sumatriptan do not change cerebral blood flow velocity in normal subjects and migraneurs.
    Diener HC; Peters C; Rudzio M; Noe A; Dichgans J; Haux R; Ehrmann R; Tfelt-Hansen P
    J Neurol; 1991 Aug; 238(5):245-50. PubMed ID: 1655985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache.
    Diener HC; Haab J; Peters C; Ried S; Dichgans J; Pilgrim A
    Headache; 1991 Apr; 31(4):205-9. PubMed ID: 1646775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimigraine drug sumatriptan increases blood flow velocity in large cerebral arteries during migraine attacks.
    Caekebeke JF; Ferrari MD; Zwetsloot CP; Jansen J; Saxena PR
    Neurology; 1992 Aug; 42(8):1522-6. PubMed ID: 1322512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in cerebral blood flow velocity after treatment with sumatriptan or placebo and implications for the pathophysiology of migraine.
    Limmroth V; May A; Auerbach P; Wosnitza G; Eppe T; Diener HC
    J Neurol Sci; 1996 Jun; 138(1-2):60-5. PubMed ID: 8791240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral blood flow velocities are reduced during attacks of unilateral migraine without aura.
    Thomsen LL; Iversen HK; Olesen J
    Cephalalgia; 1995 Apr; 15(2):109-16. PubMed ID: 7641244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sumatriptan and cerebral blood flow velocity changes during migraine attacks.
    Totaro R; De Matteis G; Marini C; Baldassarre M; Carolei A
    Headache; 1997; 37(10):635-9. PubMed ID: 9439084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale for the use of 5-HT1-like agonists in the treatment of migraine.
    Feniuk W; Humphrey PP; Perren MJ; Connor HE; Whalley ET
    J Neurol; 1991; 238 Suppl 1():S57-61. PubMed ID: 1646289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of migraine attacks with sumatriptan.
    Subcutaneous Sumatriptan International Study Group
    N Engl J Med; 1991 Aug; 325(5):316-21. PubMed ID: 1647495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a vascular factor in migraine.
    Asghar MS; Hansen AE; Amin FM; van der Geest RJ; Koning Pv; Larsson HB; Olesen J; Ashina M
    Ann Neurol; 2011 Apr; 69(4):635-45. PubMed ID: 21416486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sumatriptan in the treatment of acute migraine with aura.
    Banerjee M; Findley LJ
    Cephalalgia; 1992 Feb; 12(1):39-44. PubMed ID: 1313746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible benefit of GR43175, a novel 5-HT1-like receptor agonist, for the acute treatment of severe migraine.
    Doenicke A; Brand J; Perrin VL
    Lancet; 1988 Jun; 1(8598):1309-11. PubMed ID: 2897560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of calcitonin gene-related peptide in migraine: regional cerebral blood flow and blood flow velocity in migraine patients.
    Lassen LH; Jacobsen VB; Haderslev PA; Sperling B; Iversen HK; Olesen J; Tfelt-Hansen P
    J Headache Pain; 2008 Jun; 9(3):151-7. PubMed ID: 18437288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effects and mechanism of action of sumatriptan in migraine.
    Ferrari MD; Saxena PR
    Clin Neurol Neurosurg; 1992; 94 Suppl():S73-7. PubMed ID: 1320526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SUMATRIPTAN: a receptor-targeted treatment for migraine.
    Moskowitz MA; Cutrer FM
    Annu Rev Med; 1993; 44():145-54. PubMed ID: 8386498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography studies in headache.
    Diener HC
    Headache; 1997; 37(10):622-5. PubMed ID: 9439081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral sumatriptan in acute migraine.
    Goadsby PJ; Zagami AS; Donnan GA; Symington G; Anthony M; Bladin PF; Lance JW
    Lancet; 1991 Sep; 338(8770):782-3. PubMed ID: 1681162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sumatriptan for the treatment of migraine attacks--a review of controlled clinical trials.
    Tfelt-Hansen P
    Cephalalgia; 1993 Aug; 13(4):238-44. PubMed ID: 8397070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of asymmetry of middle cerebral artery blood velocity in unilateral migraine.
    Zwetsloot CP; Caekebeke JF; Ferrari MD
    Stroke; 1993 Sep; 24(9):1335-8. PubMed ID: 8362427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of 5-HT1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan.
    den Boer MO; Villalón CM; Heiligers JP; Humphrey PP; Saxena PR
    Br J Pharmacol; 1991 Feb; 102(2):323-30. PubMed ID: 1849764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.